Free tool
Rare disease stocks
We cover 12 companies grouped under the Rare disease theme. The median market value in the group is $26.42M. Across the group, the median move over the past trading day is 0.00%. Price change over the past year runs from −60.3% to +80.0% across the middle 80 percent of the group, with a median of −22.7%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
12 of 268 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| ILA.AX | Island Pharmaceuticals Limited | $99.59M | Micro cap | +104.35% |
| PAR.AX | Paradigm Biopharmaceuticals Limited | $96.60M | Micro cap | −22.41% |
| RCE.AX | Recce Pharmaceuticals Ltd | $81.01M | Micro cap | −12.79% |
| BOT.AX | Botanix Pharmaceuticals Limited | $39.22M | Micro cap | −87.10% |
| 520A.T | J-PHARMACEUTICALS CO LTD | $31.08M | Micro cap | −60.71% |
| 4591.T | Ribomic Inc. | $29.85M | Micro cap | −22.94% |
| 4884.T | Kringle Pharma, Inc. | $22.99M | Micro cap | −7.41% |
| 4881.T | FunPep Company Limited | $15.92M | Micro cap | −56.14% |
| IMC.AX | Immuron Limited | $8.33M | Micro cap | −46.38% |
| VBS.AX | Vectus Biosystems Limited | $6.65M | Micro cap | +87.50% |
| BIT.AX | Biotron Limited | $3.99M | Micro cap | −33.33% |
| ANR.AX | Anatara Lifesciences Ltd | $2.04M | Micro cap | +12.50% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.